Works matching IS 02681161 AND DT 2025 AND VI 40 AND IP 7


Results: 20
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial.

    Published in:
    Human Reproduction, 2025, v. 40, n. 7, p. 1357, doi. 10.1093/humrep/deaf082
    By:
    • Chi, Hongbin;
    • Song, Ying;
    • Jin, Lei;
    • Song, Xueru;
    • Wang, Xiaohong;
    • Ma, Qianhong;
    • Cao, Yunxia;
    • Liang, Xiaoyan;
    • Tan, Jichun;
    • Guan, Yichun;
    • Diao, Feiyang;
    • Li, Yanping;
    • Li, Zeli;
    • Sun, Yuqi;
    • Shu, Chang;
    • Chen, Hong;
    • Shen, Kai;
    • Qiao, Jie
    Publication type:
    Article
    17
    18
    19
    20